Market research
GCTK GlucoTrack Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2M
- P/E ratio
- 0.15
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.66
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US45824Q5071
- Market cap
- 2M
- P/E ratio
- 0.15
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.66
About
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the GCTK discussion.
No comments yet
Start a focused discussion about GCTK.